Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. I.
The DOI matches its Crossref record.
Abstract
Interferon‐sensitive (745) and interferon‐resistant (3Cl‐8) Friend leukemia cells (FLC) are highly tumorigenic for DBA/2 mice. The phenotype of interferon sensitivity or resistance does not change with in vivo passage. Daily administration of mouse interferon markedly enhanced the survival time of mice injected with either 745 or 3Cl‐8 cells. Use of quantitative methods for determining the number of FLC (colony formation in agarose and immunofluorescence) permitted us to show that potent, partially purified or highly purified mouse interferon (s.a. 0.5 to 1 × 10 9 u/mg protein) induced a 100‐ to 1,000‐fold decrease in the number of tumor cells in the peritoneal cavity in the days following inoculation of 745 or 3Cl‐8 cells. Interferon decreased the number of FLC even when treatment was initiated at a time when tumor cells were multiplying exponentially in the peritoneal cavity. There was no evidence that interferon acted as an inducer of FLC differentiation in vivo. The finding that interferon was equally effective in mice inoculated with interferonresistant cells as in mice inoculated with interferon‐sensitive cells suggests that in this experimental system interferon does not act directly on the tumor cells, but that the interferon‐induced antitumor activity is mediated by the host.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
A critical function for type I interferons in cancer immunoediting
Dunn, G. P., Bruce, A. T., Sheehan, K. C. F., Shankaran, V., Uppaluri, R., Bui, J. D., Diamond, M. S., Koebel, C. M., Arthur, C., White, J. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1213 · Cited by 605
Role of interferons and other cytokines in the regulation of the immune response
Belardelli, F. (1995) · APMIS · doi:10.1111/j.1699-0463.1995.tb01092.x · Cited by 471
Self-citationInterferon-alpha in tumor immunity and immunotherapy
Belardelli, F., Ferrantini, M., Proietti, E., & Kirkwood, J. M. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00022-3 · Cited by 337
Self-citationThe neglected role of type I interferon in the T-cell response: implications for its clinical use
Belardelli, F., & Gresser, I. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10027-x · Cited by 299
Self-citation
Metadata
- Authors
- Belardelli, F., Gresser, I., Maury, C., & Maunoury, M. ‐.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1982-12-15
- Volume
- 30
- Issue
- 6
- Pages
- 813-820
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2038461466
- Cited by
- 111
- References
- 0
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. I. https://app.cochat.ai/papers/10.1002/ijc.2910300621
- The paper
- Belardelli, F., Gresser, I., Maury, C., & Maunoury, M. ‐. (1982). Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. I. International Journal of Cancer. https://doi.org/10.1002/ijc.2910300621
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.